Robeco Institutional Asset Management B.V. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Robeco Institutional Asset Management B.V. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$362,978
-53.7%
4,052
-56.0%
0.00%
-50.0%
Q2 2023$783,288
+2.9%
9,2000.0%0.00%0.0%
Q1 2023$761,302
+184.7%
9,200
+170.6%
0.00%
+100.0%
Q4 2022$267,410
-98.7%
3,400
-98.3%
0.00%
-98.9%
Q4 2018$20,151,000
-13.9%
203,733
-0.3%
0.09%
-3.2%
Q3 2018$23,402,000
+28.1%
204,261
+0.2%
0.09%
+12.0%
Q2 2018$18,272,000203,7610.08%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders